RJA
MDWD icon

Raymond James & Associates’s MediWound MDWD Stock Holding History

Raymond James & Associates’s Portfolio MDWD Stock Details MDWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$191K Buy
+10,593
New +$193K ﹤0.01% 3658
2020
Q3 		– Sell
-1,641
Closed -$34K – 3651
2020
Q2 		$34K Hold
1,641
– – ﹤0.01% 3411
2020
Q1 		$18K Sell
1,641
-999
-38% -$18.4K ﹤0.01% 3410
2019
Q4 		$57K Buy
+2,640
New +$54.8K ﹤0.01% 3537

Other funds holding MDWD

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
YLHM
Yelin Lapidot Holdings Management Tel Aviv, Israel $480M AUM 42.17% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Raymond James & Associates's MDWD Position: Q3 2024 in Review

Raymond James & Associates opened a new position in MediWound (MDWD) in Q3 2024: 10,593 shares worth $191K. The stake represents ﹤0.01% of the portfolio and ranks #3658 among its holdings. This is a return to the name: Raymond James & Associates previously reported a position in MDWD as recently as Q2 2020.

Raymond James & Associates first reported a position in MDWD in Q4 2019 and has held it in 4 quarters since. 63 funds tracked by Wall St. Rank hold MDWD as of Q3 2024.

  • Raymond James & Associates held 10,593 shares of MediWound worth $191K as of Q3 2024.
  • MediWound was a new Raymond James & Associates position in Q3 2024.
  • MediWound made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #3658 holding.
  • Raymond James & Associates first reported a position in MediWound in Q4 2019 and has held it in 4 quarters since.
  • 63 funds tracked by Wall St. Rank held MediWound as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.